Bausch & Lomb (BLCO) Net Income towards Common Stockholders (2021 - 2026)
Bausch & Lomb posted quarterly Net Income towards Common Stockholders of -$70.0 million for Q1 2026, up 66.82% year-on-year from -$42.0 million in Q1 2025, and down 20.69% on a QoQ basis from -$58.0 million in Q4 2025.
Bausch & Lomb (BLCO) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$70.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 66.82% year-over-year to -$70.0 million; the trailing twelve-month figure through Mar 2026 stood at -$211.0 million (up 40.23% YoY), and the FY2025 full-year result was -$352.0 million, down 15.41% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$70.0 million, down from -$58.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $23.0 million in Q1 2022 and bottomed at -$211.0 million in Q1 2025.
- The 5-year median for Net Income towards Common Stockholders is -$54.5 million (2023), against an average of -$60.0 million.
- The widest annual swing landed in 2024, when Net Income towards Common Stockholders soared 110.0%; it then slumped 2800.0% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$15.0 million in 2022, then sank by 240.0% to -$51.0 million in 2023, then soared by 96.08% to -$2.0 million in 2024, then plunged by 2800.0% to -$58.0 million in 2025, then fell by 20.69% to -$70.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$70.0 million (Q1 2026), -$58.0 million (Q4 2025), and -$25.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 398.73 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 135.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 13.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 130.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 112.77 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 72.77 Mn |
| 10 | Bausch & Lomb | 5.74 Bn | 5.53 Bn | 973.00 Mn | -70.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.00 Mn |
| Dec 31, 2025 | -58.00 Mn |
| Sep 30, 2025 | -25.00 Mn |
| Jun 30, 2025 | -58.00 Mn |
| Mar 31, 2025 | -211.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | -148.00 Mn |
| Mar 31, 2024 | -163.00 Mn |
| Dec 31, 2023 | -51.00 Mn |
| Sep 30, 2023 | -80.00 Mn |
| Jun 30, 2023 | -29.00 Mn |
| Mar 31, 2023 | -88.00 Mn |
| Sep 30, 2022 | -15.00 Mn |
| Jun 30, 2022 | 7.00 Mn |
| Mar 31, 2022 | 23.00 Mn |
| Dec 31, 2021 | 54.00 Mn |
| Sep 30, 2021 | 63.00 Mn |
| Jun 30, 2021 | 46.00 Mn |
| Mar 31, 2021 | 30.00 Mn |